![]() |
|
|
Food Components and Health Laboratory, Beltsville Human Nutrition Research Center, Agricultural Research Service, USDA, Beltsville, MD 20705
* To whom correspondence should be addressed. E-mail: janet.novotny{at}ars.usda.gov.
| ABSTRACT |
|---|
|
|
|---|
60 µmol, thus showing that more strawberry anthocyanin can be absorbed with increasing dose.
| Introduction |
|---|
|
|
|---|
Strawberries, a staple fruit of the American diet, are naturally high in anthocyanins (20). Marketed year round, strawberries are the 5th highest consumed fresh fruit in the United States, and consumption rate is on the rise, having increased
50% in the previous decade (21). Therefore, strawberries offer an important vehicle for delivery of dietary anthocyanins. Strawberries and radishes are the most abundant sources of pelargonidin-based anthocyanins in the diet (22) and pelargonidin-based anthocyanins provide
3% of total anthocyanin intake (22).
Because of the potential importance of anthocyanins to the promotion of health and the prevention of chronic disease, it is important to understand factors, such as dose-response, that affect their bioavailability. Two studies have been published previously addressing the effect of dose on anthocyanin absorption. The first study showed that blood and urinary recovery of purple carrot anthocyanins was not different for a 250-g dose compared with a 500-g dose (23). The other study showed that urinary recovery of red cabbage anthocyanins increased linearly with increasing dose, although the increase in urinary recovery was not of the same magnitude as the increase in dose size (24). Both purple carrot anthocyanins and red cabbage anthocyanins are cyanidin-based. In contrast, strawberry anthocyanins are primarily pelargonidin-based. Wu et al. (25) showed that pelargonidin-based anthocyanins are absorbed and metabolized differently from cyanidin-based anthocyanins. No studies to date to our knowledge have investigated the dose response of strawberry anthocyanins.
The objective of this study was to determine the dose response of anthocyanin absorption and metabolism after consumption of strawberries. To meet this objective, a clinical feeding study was conducted in which subjects consumed pureed strawberries at 3 dose levels in a crossover study design. We analyzed urine for anthocyanin appearance as an index of anthocyanin absorption to determine whether dose size influences pelargonidin absorption and metabolism.
| Materials and Methods |
|---|
|
|
|---|
Subjects. Twelve healthy, nonsmoking volunteers from the Beltsville, MD area participated in this study. The 6 males and 6 females had a mean age of 45 ± 8.4 y and a mean BMI of 24.4 ± 3.31 kg/m2. Every subject gave written informed consent prior to participation. All procedures were approved by the MedStar Research Institute and performed according to the Helsinki Declaration.
Treatments, study design, sample collection, and diet. Strawberries were blended with a commercial mixer to obtain a homogeneous product. Blended berries were stored at –20°C until the day of treatment. Treatments consisted of the following: 1) 100 g (3.5 oz.) of blended berries; 2) 200 g (7 oz.) of blended berries; and 3) 400 g (14 oz.) of blended berries. These masses of blended berries are approximately equivalent to eating 8, 16, and 32 medium strawberries, respectively. All treatments were prepared simultaneously as a single batch. On the day of treatment, the 100-g and 200-g treatments of blended berries were mixed with 300 g and 200 g water, respectively, so that the final masses of the 3 treatments were the same. To improve palatability, 1 packet of noncaloric sweetener (Equal) was added to each treatment immediately prior to consumption. Each dose was served to subjects with 50 g of water to rinse the remaining dose from the container.
The 3 strawberry treatments were administered to subjects in a crossover experimental design. All subjects received each of the treatments in random order, with the treatment periods being separated by 1-wk breaks. During the study, subjects were instructed to avoid anthocyanin-containing foods and were provided a list of these foods. On d 1 of each treatment period, subjects consumed anthocyanin-free meals provided by the Beltsville Human Nutrition Research Center and continued to eat only foods provided by the Nutrition Research Center for the remainder of the treatment period. Following an overnight fast, subjects consumed 1 of the 3 strawberry treatments on the 2nd morning. Subjects were offered anthocyanin-free meals and snacks starting 4 h after the dose. Vitamins and supplements were prohibited throughout the study.
Subjects collected a baseline urine sample immediately prior to consuming the strawberry treatments. Additionally, subjects collected all urine produced during the 24 h following the treatment meal, with collections occurring at 2-h intervals for the first 12 h and a pooled collection from 12 to 24 h.
Extraction of anthocyanins from strawberries. Three aliquots of blended strawberries were extracted and analyzed for anthocyanin content. First, samples were freeze-dried over 72 h. Two milliliters of 10% formic acid in methanol (v:v) and 1.0 mL of malvidin 3-galactoside (10.88 µmol/L) as an internal standard were added to 75 mg of freeze-dried sample. The mixture was sonicated for 10 min, then centrifuged at 3000 x g; 10 min at 20°C. The supernatant was transferred into a 10-mL volumetric flask and the extraction repeated 3 times with 2 mL of 10% formic acid in methanol each time. All supernatants were combined in the 10 mL volumetric and the final volume was adjusted to 10 mL with 10% formic acid in methanol. Immediately prior to sample analysis, the strawberry extract was dried under nitrogen and resuspended in 10% formic acid in water.
Biological sample preparation. The total volume of each urine collection was weighed and recorded and 10-mL aliquots were stored in vials containing 2 mL of 0.44 mol/L trifluoroacetic acid and 2 mL of malvidin 3-galactoside (10.88 µmol/L) as an internal standard. All samples were stored at –80°C until analysis. Prior to HPLC quantification, samples were thawed and passed through C18-solid phase extraction cartridges to isolate and concentrate the anthocyanins. Sep-pak cartridges (Waters Associates) were conditioned with 5 mL of methanol and then 5 mL of 0.44 mol/L aqueous trifluoroacetic acid prior to adding sample. After the sample was added, water soluble compounds were eluted with 5 mL of 0.44 mol/L aqueous trifluoroacetic acid, followed by the elution of anthocyanins with 5 mL of 10% formic acid in methanol. Recovery of the internal standard was 84%. Samples were dried under nitrogen and reconstituted in methanol:10% aqueous formic acid (1:9).
HPLC/DAD/ion-trap MS analysis of anthocyanins. We analyzed the anthocyanins on an Agilent MSD SL ion trap mass spectrometer equipped with an electrospray ionization interface, an 1100 HPLC, a diode array detector (DAD), and ChemStation software. The column used was a Luna C18 column (5 µm, 250 mm x 4.6 mm) and a Fusion-RP guard column (Phenomenex). The HPLC utilized a binary solvent system with solvent A as 89:10:1 water:formic acid:methanol and solvent B as 10% formic acid in methanol. For strawberry anthocyanin analysis, the solvent system was isocratic at 84% solvent A and 16% solvent B and the system used a flow rate of 0.8 mL/min. For identification of urinary anthocyanins and metabolites, the solvents were held at 83% solvent A and 17% solvent B for 30 min. From 30 min to 60 min, there was a linear ramp to 100% solvent B. For 5 min, the solvents were held at 100% solvent B, followed by a return to starting conditions over 5 min. For quantitative analysis of anthocyanins and metabolites in urine, the starting conditions were 90% solvent A and 10% solvent B. There was a linear ramp to 86% solvent A from 0 to 5 min, which was held from 5 to 36 min. From 36 to 41 min, there was a linear ramp to 100% solvent B and this was held for 4 min, followed by a linear gradient back to initial conditions. For all analyses, the DAD was monitored at 520 nm and the injection volume was 50 µL. MS and electrospray ionization interface, conditions were as follows: nebulizer, 60 psi; dry gas (N2), 11 L/min; dry temperature, 350°C; trap drive, 66; skimmer, 40 V; octopole RF amplitude, 200 Vpp; capillary exit, 102.7 V. The ion trap mass spectrometer was operated in positive ion mode scanning from 100 to 800 mass-to-charge ratio (m/z). Trap ICC was 30,000 and maximal accumulation time was 200 ms.
Calculations and statistics. Malvidin 3-galactoside was used as an internal standard to account for sample loss during extraction. Molar concentrations of individual strawberry anthocyanins in treatments and urine were calculated using external standard curves of pelargonidin 3-glucoside for pelargonidin-based anthocyanins and cyanidin 3-glucoside for cyanidin-based anthocyanins.
The data were tested for normality (using the Kolmogorov-Smirnov test) and equal variance (using the Levene Median test), then we used a 1-way repeated measures ANOVA to compare urine responses among treatments, with P < 0.05 considered significant. The Tukey method was used for pairwise comparisons. Statistical analysis was performed using the SigmaStat Software Package (version 3.0, SPSS). Linear regression analysis of mean anthocyanin excretion for the 3 doses was performed using Microsoft Excel 2003.
| Results |
|---|
|
|
|---|
Anthocyanins in strawberry treatments. Four peaks were detected in the strawberry treatment extract in addition to the internal standard, as determined by ion trap MS. Anthocyanins detected in the strawberry treatments were cyanidin-3-glucoside, pelargonidin-3-glucoside, pelargonidin-3-rutinoside, and pelargonidin-3-(6''-acetoyl)glucoside, which were detected previously in strawberries by Wu et al. (20). Pelargonidin-3-glucoside was the major anthocyanin in the strawberry treatment, comprising 88% of total anthocyanin content, with a concentration of 133.4 nmol/g of blended berries. Cyanidin-3-glucoside and pelargonidin-3-rutinoside were present in concentrations of 11.6 nmol/g and 6.8 nmol/g of blended berries, respectively. The 4th anthocyanin peak, pelargonidin-3-(6''-acetoyl)glucoside, was below the quantification limit. The structures of pelargonidin aglycone and cyanidin aglycone are shown in Figure 1. Total anthocyanin contents of treatments were 15 µmol (6.7 mg), 30 µmol (13.4 mg), and 60 µmol (26.8 mg) of anthocyanins for the 100-g, 200-g, and 400-g treatments, respectively. Note that the concentration of pelargonidin 3-rutinoside is based on pelargonidin 3-glucoside molar equivalents.
|
|
|
|
2% of the dose was recovered during the 24-h collection period. Regression analysis of mean anthocyanin excretion for the 3 doses showed that the relationship between anthocyanin dose and urinary recovery was linear with an R value of 0.99.
|
|
|
| Discussion |
|---|
|
|
|---|
Generally, flavonoids are metabolized to glucuronidated and/or sulfated derivatives, although most anthocyanin studies have reported detection of only native glycosylated forms (28). However, recent studies have reported detection of glucuronidated, methylated, and/or sulfated forms (25–27,29). We observed 4 anthocyanin peaks in urine originating from the strawberry dose. One peak represented the parent compound pelargonidin 3-glucoside and the remaining 3 peaks were monoglucuronides. Felgines et al. (26) observed these peaks, in addition to 1 sulfoconjugate and pelargonidin aglycone, after humans consumed 200 g strawberries. Our anthocyanin doses were all lower (15, 30, and 60 µmol) than those given in the study by Felgines et al. (26) (179 µmol), which may explain why we observed fewer compounds in the urine. Similar to our results, a glucuronide derivative of pelargonidin was also found to be the major metabolite of pelargonidin 3-glucoside in rat plasma and urine (27,29) and in pigs (25).
In this study, anthocyanin recovery in urine increased linearly with increasing dose and the increase in anthocyanin recovery was of the same magnitude as the increase in dose. Two studies addressing anthocyanin dose response have been published previously. In one study, volunteers consumed 100, 200, or 300 g red cabbage, which is high in cyanidin-based anthocyanins, many of which are acylated. Urinary recovery of anthocyanins increased linearly with dose, although the magnitude of the increase was only
50% the increase in anthocyanin dose (24). In a study of purple carrots, urinary recovery of anthocyanins (again, predominantly cyanidin-based and largely acylated) did not differ for a 250-g vs. a 500-g cooked dose. Total anthocyanin dose for the red cabbage and carrot studies were 138–414 µmol and 357–714 µmol, respectively. The differing results among these studies may be related to anthocyanin backbone, food matrix, or dose sizes used. In sorting the results according to dose sizes used, the study using the lowest anthocyanin dose (strawberry study) revealed increasing urinary anthocyanin recovery with a magnitude matching the increase in dose, the study with the intermediate level of anthocyanins (red cabbage study) showed moderately increasing urinary anthocyanin recovery with increasing dose, and the study with the highest dose of anthocyanins (purple carrot study) showed no increase in urinary anthocyanin recovery with increasing dose, suggesting saturation of absorption mechanisms. It is possible that reduced absorption efficiency would be observed for strawberry anthocyanins consumed at higher doses, but higher doses would not represent normal intake levels.
Anthocyanin recoveries over 24 h of urine collection for this study were
2% of the anthocyanins dose administered. Generally, previous reports show anthocyanin with other aglycon backbones exhibit much lower recoveries, and in most cases, only native anthocyanin forms were detected. Most reports of anthocyanin recoveries in urine refer to collection periods of 5–8 h (instead of 24 h, as in this study). For comparison, anthocyanin excretions are >50% in the first 4 h, as observed in this study and others (23,24). Some of the previously reported anthocyanin recoveries include 0.077% in 4 h for elderberry (30), 0.053% in 5 h for elderberry (31), 0.003–0.012% in 6 h for elderberry (32), 0.37% in 7 h for elderberry (31), 0.004% in 6 h for blueberry (30), 0.02–0.05% in 5 h for blackcurrant juice (33), 0.04% in 7 h for blackcurrant (31), <0.03% in 6 h for red wine or grape juice (34), 0.18% in 7 h for red wine (35), 0.23% in 7 h for red grape juice (35), 0.20% in 7 h for a mixed berry extract of blackcurrant, boysenberry, and blueberry (36), 0.02–0.038 in 24 h for purple carrots (23), and 0.036–0.073% in 24 h for red cabbage (24). In contrast, anthocyanins from strawberries appear to be more effectively absorbed, showing 2% urinary recovery after 24 h in this study and 1.8% urinary recovery after 24 h in a study by Felgines et al. (26). Further, when pigs were administered marionberry containing cyanidin and pelargonidin derivatives, urinary recoveries were 0.084% for cyanidin 3-rutinoside, 0.087% for cyanidin 3-glucoside, and 0.58% for pelargonidin 3-glucoside, again suggesting that pelargonidin-based anthocyanins may be more effectively absorbed than other anthocyanins (25).
Approximately 98% of the anthocyanin dose was not recovered in urine. It is unknown what portion of this was deposited into tissues and what portion was excreted into feces. Regardless of the apparently low absorption efficiency of anthocyanins, the portion that is absorbed may be very biologically active. In addition, the portion that remains in the gastrointestinal tract may convey important health benefits to intestinal tissue. Therefore, the apparently low absorption efficiency does not imply low potential for health benefits.
In summary, anthocyanins from strawberries exhibit a linear dose response over ranges of 15–60 µmol. In addition, 24-h urinary recoveries observed in this study were substantially higher than those reported for most other anthocyanin bioavailability studies, suggesting that pelargonidin-based anthocyanins may be more efficiently absorbed than other anthocyanins. However, these higher recoveries may be at least partially related to the lower doses administered in this study compared with others.
| FOOTNOTES |
|---|
Manuscript received 21 December 2007. Initial review completed 15 January 2008. Revision accepted 27 February 2008.
| LITERATURE CITED |
|---|
|
|
|---|
1. Bell DR, Gochenaur K. Direct vasoactive and vasoprotective properties of anthocyanin-rich extracts. J Appl Physiol. 2006;100:1164–70.
2. Dai J, Patel JD, Mumper RJ. Characterization of blackberry extract and its antiproliferative and anti-inflammatory properties. J Med Food. 2007;10:258–65.[Medline]
3. Kaplan M, Hayek T, Raz A, Coleman R, Dornfeld L, Vaya J, Aviram M. Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development of atherosclerosis. J Nutr. 2001;131:2082–9.
4. Rechner AR, Kroner C. Anthocyanins and colonic metabolites of dietary polyphenols inhibit platelet function. Thromb Res. 2005;116:327–34.[Medline]
5. Kang SY, Seeram NP, Nair MG, Bourquin LD. Tart cherry anthocyanins inhibit tumor development in Apc(Min) mice and reduce proliferation of human colon cancer cells. Cancer Lett. 2003;194:13–9.[Medline]
6. Katsube N, Iwashita K, Tsushida T, Yamaki K, Kobori M. Induction of apoptosis in cancer cells by bilberry (Vaccinium myrtillus) and the anthocyanins. J Agric Food Chem. 2003;51:68–75.[Medline]
7. Lala G, Malik M, Zhao C, He J, Kwon Y, Giusti MM, Magnuson BA. Anthocyanin-rich extracts inhibit multiple biomarkers of colon cancer in rats. Nutr Cancer. 2006;54:84–93.[Medline]
8. Ding M, Feng R, Wang SY, Bowman L, Lu Y, Qian Y, Castranova V, Jiang BH, Shi X. Cyanidin-3-glucoside, a natural product derived from blackberry, exhibits chemopreventive and chemotherapeutic activity. J Biol Chem. 2006;281:17359–68.
9. Yi W, Fischer J, Krewer G, Akoh CC. Phenolic compounds from blueberries can inhibit colon cancer cell proliferation and induce apoptosis. J Agric Food Chem. 2005;53:7320–9.[Medline]
10. Hecht SS, Huang C, Stoner GD, Li J, Kenney PM, Sturla SJ, Carmella SG. Identification of cyanidin glycosides as constituents of freeze-dried black raspberries which inhibit anti-benzo[a]pyrene-7,8-diol-9,10-epoxide induced NFkappaB and AP-1 activity. Carcinogenesis. 2006;27:1617–26.
11. Andres-Lacueva C, Shukitt-Hale B, Galli RL, Jauregui O, Lamuela-Raventos RM, Joseph JA. Anthocyanins in aged blueberry-fed rats are found centrally and may enhance memory. Nutr Neurosci. 2005;8:111–20.[Medline]
12. Hartman RE, Shah A, Fagan AM, Schwetye KE, Parsadanian M, Schulman RN, Finn MB, Holtzman DM. Pomegranate juice decreases amyloid load and improves behavior in a mouse model of Alzheimer's disease. Neurobiol Dis. 2006;24:506–15.[Medline]
13. Galli RL, Shukitt-Hale B, Youdim KA, Joseph JA. Fruit polyphenolics and brain aging: nutritional interventions targeting age-related neuronal and behavioral deficits. Ann N Y Acad Sci. 2002;959:128–32.[Medline]
14. Goyarzu P, Malin DH, Lau FC, Taglialatela G, Moon WD, Jennings R, Moy E, Moy D, Lippold S, et al. Blueberry supplemented diet: effects on object recognition memory and nuclear factor-kappa B levels in aged rats. Nutr Neurosci. 2004;7:75–83.[Medline]
15. Joseph JA, Shukitt-Hale B, Casadesus G. Reversing the deleterious effects of aging on neuronal communication and behavior: beneficial properties of fruit polyphenolic compounds. Am J Clin Nutr. 2005;81:S313–6.
16. Jayaprakasam B, Vareed SK, Olson LK, Nair MG. Insulin secretion by bioactive anthocyanins and anthocyanidins present in fruits. J Agric Food Chem. 2005;53:28–31.[Medline]
17. Jayaprakasam B, Olson LK, Schutzki RE, Tai MH, Nair MG. Amelioration of obesity and glucose intolerance in high-fat-fed C57BL/6 mice by anthocyanins and ursolic acid in Cornelian cherry (Cornus mas). J Agric Food Chem. 2006;54:243–8.[Medline]
18. Loren DJ, Seeram NP, Schulman RN, Holtzman DM. Maternal dietary supplementation with pomegranate juice is neuroprotective in an animal model of neonatal hypoxic-ischemic brain injury. Pediatr Res. 2005;57:858–64.[Medline]
19. West T, Atzeva M, Holtzman DM. Pomegranate polyphenols and resveratrol protect the neonatal brain against hypoxic-ischemic injury. Dev Neurosci. 2007;29:363–72.[Medline]
20. Wu X, Prior RL. Systematic identification and characterization of anthocyanins by HPLC-ESI-MS/MS in common foods in the United States: fruits and berries. J Agric Food Chem. 2005;53:2589–99.[Medline]
21. Boriss H, Brunke H, Kreith M. Commodity profile: strawberries. Davis (CA): Agriculture Issues Center, Agricultural Marketing Resource Center; 2006.
22. Wu X, Beecher GR, Holden JM, Haytowitz DB, Gebhardt SE, Prior RL. Concentrations of anthocyanins in common foods in the United States and estimation of normal consumption. J Agric Food Chem. 2006;54:4069–75.[Medline]
23. Kurilich AC, Clevidence BA, Britz SJ, Simon PW, Novotny JA. Plasma and urine responses are lower for acylated vs nonacylated anthocyanins from raw and cooked purple carrots. J Agric Food Chem. 2005;53:6537–42.[Medline]
24. Charron CS, Clevidence BA, Britz SJ, Novotny JA. Effect of dose size on bioavailability of acylated and nonacylated anthocyanins from red cabbage (Brassica oleracea L. Var. capitata). J Agric Food Chem. 2007;55:5354–62.[Medline]
25. Wu X, Pittman HE III, Prior RL. Pelargonidin is absorbed and metabolized differently than cyanidin after marionberry consumption in pigs. J Nutr. 2004;134:2603–10.
26. Felgines C, Talavéra S, Gonthier MP, Texier O, Scalbert A, Lamaison JL, Rémésy C. Strawberry anthocyanins are recovered in urine as glucuro- and sulfoconjugates in humans. J Nutr. 2003;133:1296–301.
27. Felgines C, Texier O, Besson C, Lyan B, Lamaison JL, Scalbert A. Strawberry pelargonidin glycosides are excreted in urine as intact glycosides and glucuronidated pelargonidin derivatives in rats. Br J Nutr. 2007;98:1126–31.[Medline]
28. Manach C, Williamson G, Morand C, Scalbert A, Remesy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr. 2005;81:S230–42.
29. El Mohsen MA, Marks J, Kuhnle G, Moore K, Debnam E, Srai SK, Rice-Evans C, Spencer JPE. Absorption, tissue distribution and excretion of pelargonidin and its metabolites following oral administration to rats. Br J Nutr. 2006;95:51–8.[Medline]
30. Wu X, Cao G, Prior RL. Absorption and metabolism of anthocyanins in elderly women after consumption of elderberry or blueberry. J Nutr. 2002;132:1865–71.
31. Bitsch I, Janssen M, Netzel M, Strass G, Frank T. Bioavailability of anthocyanidin-3-glycosides following consumption of elderberry extract and blackcurrant juice. Int J Clin Pharmacol Ther. 2004;42:293–300.[Medline]
32. Mulleder U, Murkovic M, Pfannhauser W. Urinary excretion of cyanidin glycosides. J Biochem Biophys Methods. 2002;53:61–6.[Medline]
33. Netzel M, Strass G, Janssen M, Bitsch I, Bitsch R. Bioactive anthocyanins detected in human urine after ingestion of blackcurrant juice. J Environ Pathol Toxicol Oncol. 2001;20:89–95.[Medline]
34. Bub A, Watzl B, Heeb D, Rechkemmer G, Briviba K. Malvidin-3-glucoside bioavailability in humans after ingestion of red wine, dealcoholized red wine and red grape juice. Eur J Nutr. 2001;40:113–20.[Medline]
35. Frank T, Netzel M, Strass G, Bitsch R, Bitsch I. Bioavailability of anthocyanidin-3-glucosides following consumption of red wine and red grape juice. Can J Physiol Pharmacol. 2003;81:423–35.[Medline]
36. McGhie TK, Ainge GD, Barnett LE, Cooney JM, Jensen DJ. Anthocyanin glycosides from berry fruit are absorbed and excreted unmetabolized by both humans and rats. J Agric Food Chem. 2003;51:4539–48.[Medline]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||